RGA Stock Analysis — Reinsurance Group of America
Sector: Financials
AI Verdict
RGA is cheap for the growth you're getting, and the moat of sticky reinsurance contracts makes the earnings jump look credible rather than fragile.
Competitive Moat
RGA specializes in life and health reinsurance, benefiting from high regulatory barriers and long-term client relationships that make switching costly and complex. Their actuarial expertise and global scale allow them to price risk more accurately than smaller competitors.
Summary
RGA's forward P/E of 7.7x paired with nearly 50% expected EPS growth makes it a standout among financial stocks.
Where It Stands
With a forward P/E of 7.7x versus the financial sector median of 14x and analyst consensus for 49.9% EPS growth, RGA trades at a steep discount for its projected earnings surge.
Key Metrics
- Trailing P/E: 11.6x
- Forward P/E: 7.7x
- PEG Ratio: 0.23
- Earnings Growth: +0.5%
- Revenue Growth: +0.2%
- Dividend Yield: 0.02%
- 52-Week High: $229.21
- 52-Week Low: $165.52
Analyst Consensus
9 Buy · 4 Hold · 1 Sell (14 analysts)
Bull Case
Analysts expect EPS to jump 49.9% next year, yet the stock trades at just 7.7x forward earnings, suggesting the market is heavily discounting its growth.
Bear Case
If RGA rerates to the sector median P/E of 14x only after growth slows, investors could see little multiple expansion despite strong earnings, limiting upside if expectations are already priced in.
Catalyst to Watch
Quarterly earnings beats or upward guidance revisions could force a rerating if the 49.9% EPS growth materializes.